Skinmed at CES & JP Morgan Healthcare Week 2026
Skinmed at CES & JP Morgan Healthcare Week 2026
Skinmed at CES & JP Morgan Healthcare Week 2026
Join us in January as we showcase how AI-enhanced telehealth is democratizing dermatology — from the world's largest tech event to healthcare's premier investment symposium.
Join us in January as we showcase how AI-enhanced telehealth is democratizing dermatology — from the world's largest tech event to healthcare's premier investment symposium.
Join us in January as we showcase how AI-enhanced telehealth is democratizing dermatology — from the world's largest tech event to healthcare's premier investment symposium.
December 4, 2025
December 4, 2025
December 4, 2025
This January, Skinmed will join thousands of innovators, investors, and healthcare leaders at two of the world's most influential events:
CES 2026 in Las Vegas and the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. These appearances mark a pivotal moment in our journey from a French medtech startup serving rural Dordogne to a global platform poised to transform dermatology access worldwide. We're excited to share our story, demonstrate our technology, and connect with partners who share our vision.
Here's what you need to know about where we'll be, what we're showcasing, and how you can connect with our team.
🎯 CES 2026 Las Vegas · January 6-9, 2026 | Digital Health Summit
Why CES?
CES is where the future of technology meets the future of healthcare.
As one of only [X] companies selected for the Digital Health Summit,
we'll be showcasing how Skinmed bridges the gap between cutting-edge
AI innovation and life-saving medical expertise.
What We're Demonstrating
At our booth, visitors will experience:
Live Technology Demo: See our medical-grade dermoscopy equipment
and AI-powered platform in actionThe Hybrid Intelligence Model: Learn how we combine AI pre-screening
with 100% board-certified dermatologist validationReal Impact Stories: Hear from patients whose lives were changed
through early detectionPharmacy Network Expansion: Explore partnership opportunities
to bring Skinmed to your community
Key Themes
Our CES presence will focus on three core messages:
Accessibility: Healthcare innovation means nothing if it
doesn't reach underserved communitiesHuman-Centered AI: Technology amplifies expertise — it doesn't
replace itProven Traction: From 0 to 600+ pharmacies and 17,000+ screenings
in under 3 years
Who Should Visit Our Booth?
Healthcare systems exploring telehealth integration
Pharmacy chains interested in value-added services
Digital health investors
Medical device distributors
Policy makers focused on healthcare access
Media covering healthtech innovation
CES 2026 Fast Facts
📍 Location: Las Vegas Convention Center
📅 Dates: January 6-9, 2026
🎫 Digital Health Summit Pass required
🔗 More info: CES.tech/DigitalHealth
💼 J.P. Morgan 44th Annual Healthcare Conference · January 12-15, 2026 | San Francisco
The Premier Healthcare Investment Event
The J.P. Morgan Healthcare Conference is where the world's most
promising healthcare companies meet the investors who will fuel
their growth. With over 8,000 attendees including institutional
investors, VCs, and industry leaders, it's the ideal platform to
share Skinmed's global expansion vision.
Our Investment Thesis
Skinmed represents a unique convergence of:
Massive Market Opportunity: $14.8B global teledermatology
market by 2032 (16.8% CAGR)Proven Business Model: 600+ pharmacy partners generating
recurring revenue with strong unit economicsRegulatory Clarity: GDPR-compliant platform with FDA Class IIb
track for U.S. market entryScalable Infrastructure: Pharmacy deployment model requires
no brick-and-mortar capexClinical Validation: 2024 study confirms concordance with
pathology results
What We're Seeking
At JPM, we're exploring:
✓ Series A funding to accelerate U.S. market entry
✓ Strategic partnerships with healthcare systems and payers
✓ Distribution agreements for North American expansion
✓ Technology licensing opportunities
Schedule a Meeting
Our leadership team will be available for one-on-one meetings
throughout the conference. Topics we're eager to discuss:
Market expansion strategy (Europe → North America → APAC)
Regulatory roadmap and FDA clearance timeline
Unit economics and pathway to profitability
Corporate wellness and occupational health opportunities
Strategic M&A or partnership scenarios
JPM 2026 Fast Facts
📍 Location: Westin St. Francis Hotel, San Francisco
📅 Dates: January 12-15, 2026
🎟️ Invitation-only event
Our Journey: Local Impact, Global Vision
When we founded Skinmed in rural Dordogne in 2022, we had a simple
but ambitious goal: ensure that geography never determines access
to expert dermatological care.
The Journey So Far
2022: Founded in Saint-Sulpice-de-Roumagnac
2023: First 100 pharmacy partners deployed
Trophées Bossons Futé Award (ANAPIX partnership)
2024: 600+ pharmacies nationwide
17,000+ screenings completed
Clinical validation study published
2025: Vivatech 2025 selection
Presidential reception at Élysée Palace
Preparing for international expansion
What Makes January 2026 Different?
CES and JPM represent our transition from French success story
to global healthcare innovator. We're not just showcasing technology —
we're demonstrating a replicable model for democratizing specialist
access through existing community infrastructure.
The dermatology shortage isn't a French problem. It's a global crisis.
And Skinmed's pharmacy-based deployment model works anywhere there
are trusted community pharmacies — which is everywhere.
This January, Skinmed will join thousands of innovators, investors, and healthcare leaders at two of the world's most influential events:
CES 2026 in Las Vegas and the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. These appearances mark a pivotal moment in our journey from a French medtech startup serving rural Dordogne to a global platform poised to transform dermatology access worldwide. We're excited to share our story, demonstrate our technology, and connect with partners who share our vision.
Here's what you need to know about where we'll be, what we're showcasing, and how you can connect with our team.
🎯 CES 2026 Las Vegas · January 6-9, 2026 | Digital Health Summit
Why CES?
CES is where the future of technology meets the future of healthcare.
As one of only [X] companies selected for the Digital Health Summit,
we'll be showcasing how Skinmed bridges the gap between cutting-edge
AI innovation and life-saving medical expertise.
What We're Demonstrating
At our booth, visitors will experience:
Live Technology Demo: See our medical-grade dermoscopy equipment
and AI-powered platform in actionThe Hybrid Intelligence Model: Learn how we combine AI pre-screening
with 100% board-certified dermatologist validationReal Impact Stories: Hear from patients whose lives were changed
through early detectionPharmacy Network Expansion: Explore partnership opportunities
to bring Skinmed to your community
Key Themes
Our CES presence will focus on three core messages:
Accessibility: Healthcare innovation means nothing if it
doesn't reach underserved communitiesHuman-Centered AI: Technology amplifies expertise — it doesn't
replace itProven Traction: From 0 to 600+ pharmacies and 17,000+ screenings
in under 3 years
Who Should Visit Our Booth?
Healthcare systems exploring telehealth integration
Pharmacy chains interested in value-added services
Digital health investors
Medical device distributors
Policy makers focused on healthcare access
Media covering healthtech innovation
CES 2026 Fast Facts
📍 Location: Las Vegas Convention Center
📅 Dates: January 6-9, 2026
🎫 Digital Health Summit Pass required
🔗 More info: CES.tech/DigitalHealth
💼 J.P. Morgan 44th Annual Healthcare Conference · January 12-15, 2026 | San Francisco
The Premier Healthcare Investment Event
The J.P. Morgan Healthcare Conference is where the world's most
promising healthcare companies meet the investors who will fuel
their growth. With over 8,000 attendees including institutional
investors, VCs, and industry leaders, it's the ideal platform to
share Skinmed's global expansion vision.
Our Investment Thesis
Skinmed represents a unique convergence of:
Massive Market Opportunity: $14.8B global teledermatology
market by 2032 (16.8% CAGR)Proven Business Model: 600+ pharmacy partners generating
recurring revenue with strong unit economicsRegulatory Clarity: GDPR-compliant platform with FDA Class IIb
track for U.S. market entryScalable Infrastructure: Pharmacy deployment model requires
no brick-and-mortar capexClinical Validation: 2024 study confirms concordance with
pathology results
What We're Seeking
At JPM, we're exploring:
✓ Series A funding to accelerate U.S. market entry
✓ Strategic partnerships with healthcare systems and payers
✓ Distribution agreements for North American expansion
✓ Technology licensing opportunities
Schedule a Meeting
Our leadership team will be available for one-on-one meetings
throughout the conference. Topics we're eager to discuss:
Market expansion strategy (Europe → North America → APAC)
Regulatory roadmap and FDA clearance timeline
Unit economics and pathway to profitability
Corporate wellness and occupational health opportunities
Strategic M&A or partnership scenarios
JPM 2026 Fast Facts
📍 Location: Westin St. Francis Hotel, San Francisco
📅 Dates: January 12-15, 2026
🎟️ Invitation-only event
Our Journey: Local Impact, Global Vision
When we founded Skinmed in rural Dordogne in 2022, we had a simple
but ambitious goal: ensure that geography never determines access
to expert dermatological care.
The Journey So Far
2022: Founded in Saint-Sulpice-de-Roumagnac
2023: First 100 pharmacy partners deployed
Trophées Bossons Futé Award (ANAPIX partnership)
2024: 600+ pharmacies nationwide
17,000+ screenings completed
Clinical validation study published
2025: Vivatech 2025 selection
Presidential reception at Élysée Palace
Preparing for international expansion
What Makes January 2026 Different?
CES and JPM represent our transition from French success story
to global healthcare innovator. We're not just showcasing technology —
we're demonstrating a replicable model for democratizing specialist
access through existing community infrastructure.
The dermatology shortage isn't a French problem. It's a global crisis.
And Skinmed's pharmacy-based deployment model works anywhere there
are trusted community pharmacies — which is everywhere.
This January, Skinmed will join thousands of innovators, investors, and healthcare leaders at two of the world's most influential events:
CES 2026 in Las Vegas and the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. These appearances mark a pivotal moment in our journey from a French medtech startup serving rural Dordogne to a global platform poised to transform dermatology access worldwide. We're excited to share our story, demonstrate our technology, and connect with partners who share our vision.
Here's what you need to know about where we'll be, what we're showcasing, and how you can connect with our team.
🎯 CES 2026 Las Vegas · January 6-9, 2026 | Digital Health Summit
Why CES?
CES is where the future of technology meets the future of healthcare.
As one of only [X] companies selected for the Digital Health Summit,
we'll be showcasing how Skinmed bridges the gap between cutting-edge
AI innovation and life-saving medical expertise.
What We're Demonstrating
At our booth, visitors will experience:
Live Technology Demo: See our medical-grade dermoscopy equipment
and AI-powered platform in actionThe Hybrid Intelligence Model: Learn how we combine AI pre-screening
with 100% board-certified dermatologist validationReal Impact Stories: Hear from patients whose lives were changed
through early detectionPharmacy Network Expansion: Explore partnership opportunities
to bring Skinmed to your community
Key Themes
Our CES presence will focus on three core messages:
Accessibility: Healthcare innovation means nothing if it
doesn't reach underserved communitiesHuman-Centered AI: Technology amplifies expertise — it doesn't
replace itProven Traction: From 0 to 600+ pharmacies and 17,000+ screenings
in under 3 years
Who Should Visit Our Booth?
Healthcare systems exploring telehealth integration
Pharmacy chains interested in value-added services
Digital health investors
Medical device distributors
Policy makers focused on healthcare access
Media covering healthtech innovation
CES 2026 Fast Facts
📍 Location: Las Vegas Convention Center
📅 Dates: January 6-9, 2026
🎫 Digital Health Summit Pass required
🔗 More info: CES.tech/DigitalHealth
💼 J.P. Morgan 44th Annual Healthcare Conference · January 12-15, 2026 | San Francisco
The Premier Healthcare Investment Event
The J.P. Morgan Healthcare Conference is where the world's most
promising healthcare companies meet the investors who will fuel
their growth. With over 8,000 attendees including institutional
investors, VCs, and industry leaders, it's the ideal platform to
share Skinmed's global expansion vision.
Our Investment Thesis
Skinmed represents a unique convergence of:
Massive Market Opportunity: $14.8B global teledermatology
market by 2032 (16.8% CAGR)Proven Business Model: 600+ pharmacy partners generating
recurring revenue with strong unit economicsRegulatory Clarity: GDPR-compliant platform with FDA Class IIb
track for U.S. market entryScalable Infrastructure: Pharmacy deployment model requires
no brick-and-mortar capexClinical Validation: 2024 study confirms concordance with
pathology results
What We're Seeking
At JPM, we're exploring:
✓ Series A funding to accelerate U.S. market entry
✓ Strategic partnerships with healthcare systems and payers
✓ Distribution agreements for North American expansion
✓ Technology licensing opportunities
Schedule a Meeting
Our leadership team will be available for one-on-one meetings
throughout the conference. Topics we're eager to discuss:
Market expansion strategy (Europe → North America → APAC)
Regulatory roadmap and FDA clearance timeline
Unit economics and pathway to profitability
Corporate wellness and occupational health opportunities
Strategic M&A or partnership scenarios
JPM 2026 Fast Facts
📍 Location: Westin St. Francis Hotel, San Francisco
📅 Dates: January 12-15, 2026
🎟️ Invitation-only event
Our Journey: Local Impact, Global Vision
When we founded Skinmed in rural Dordogne in 2022, we had a simple
but ambitious goal: ensure that geography never determines access
to expert dermatological care.
The Journey So Far
2022: Founded in Saint-Sulpice-de-Roumagnac
2023: First 100 pharmacy partners deployed
Trophées Bossons Futé Award (ANAPIX partnership)
2024: 600+ pharmacies nationwide
17,000+ screenings completed
Clinical validation study published
2025: Vivatech 2025 selection
Presidential reception at Élysée Palace
Preparing for international expansion
What Makes January 2026 Different?
CES and JPM represent our transition from French success story
to global healthcare innovator. We're not just showcasing technology —
we're demonstrating a replicable model for democratizing specialist
access through existing community infrastructure.
The dermatology shortage isn't a French problem. It's a global crisis.
And Skinmed's pharmacy-based deployment model works anywhere there
are trusted community pharmacies — which is everywhere.
— Jennifer Gauthier, CEO & Co-Founder
— Jennifer Gauthier, CEO & Co-Founder
— Jennifer Gauthier, CEO & Co-Founder
our journal
our journal
our journal
More insights for you.
More insights for you.
More insights for you.
Explore more reflections, guidance, and practical tools to support your growth and well-being.
Explore more reflections, guidance, and practical tools to support your growth and well-being.
Explore more reflections, guidance, and practical tools to support your growth and well-being.
Early detection saves lives. Learn the five warning signs dermatologists use to identify suspicious lesions — and why regular skin self-exams matter more than you think.
Early detection saves lives. Learn the five warning signs dermatologists use to identify suspicious lesions — and why regular skin self-exams matter more than you think.
Early detection saves lives. Learn the five warning signs dermatologists use to identify suspicious lesions — and why regular skin self-exams matter more than you think.
AI doesn't replace dermatologists — it amplifies them. Explore the hybrid intelligence model that's making expert diagnosis faster, more accurate, and universally accessible.
AI doesn't replace dermatologists — it amplifies them. Explore the hybrid intelligence model that's making expert diagnosis faster, more accurate, and universally accessible.
AI doesn't replace dermatologists — it amplifies them. Explore the hybrid intelligence model that's making expert diagnosis faster, more accurate, and universally accessible.
Your questions.
Answered.
Not sure where to start? These answers might help you feel more confident as you begin.
Didn’t find your answer? Send us a message — we’ll respond with care and clarity.
How does Skinmed work?
Skinmed makes expert dermatology accessible through your local pharmacy. Simply visit a Skinmed-enabled location where a trained pharmacist will capture high-definition images of your skin concern using medical-grade equipment. Your images are securely transmitted to board-certified dermatologists who review every case and provide a detailed report within 48 hours.
If specialist care is needed, we coordinate referrals and follow-up. No appointments, no long waits — just accessible expert care when you need it.
How does Skinmed work?
Skinmed makes expert dermatology accessible through your local pharmacy. Simply visit a Skinmed-enabled location where a trained pharmacist will capture high-definition images of your skin concern using medical-grade equipment. Your images are securely transmitted to board-certified dermatologists who review every case and provide a detailed report within 48 hours.
If specialist care is needed, we coordinate referrals and follow-up. No appointments, no long waits — just accessible expert care when you need it.
Is Skinmed available in my area?
Is Skinmed available in my area?
Skinmed currently operates through 1000+ partner pharmacies across France, with rapid expansion underway.
US pilot programs are launching in 2026. To find a Skinmed-enabled pharmacy near you or to express interest in bringing Skinmed to your community, contact us directly.
How accurate is the diagnosis?
How accurate is the diagnosis?
Every Skinmed diagnosis undergoes mandatory review by board-certified dermatologists registered with medical authorities. Our AI-powered pre-screening assists triage, but 100% of final diagnoses are validated by human experts.
Our 2024 clinical study demonstrates concordance between Skinmed diagnoses, in-person dermatology consultations, and pathology results.
Quality and accuracy are never compromised for speed.
What conditions can Skinmed screen for?
What conditions can Skinmed screen for?
Skinmed screens for a wide range of skin conditions including:
Melanoma and other skin cancers (basal cell, squamous cell)
Pre-cancerous lesions (actinic keratosis)
Atypical moles requiring monitoring
Common dermatological conditions (eczema, psoriasis, rosacea)
Suspicious lesions requiring specialist evaluation
Our platform provides risk-stratified recommendations: routine monitoring, primary care follow-up, dermatologist consultation, or urgent specialist referral.
What is Skinmed's regulatory status?
What is Skinmed's regulatory status?
Skinmed operates as a GDPR-compliant telehealth platform in France.
All dermatologists are licensed and registered with French medical authorities (RPPS).
The AI technology (developed by ANAPIX Medical) is currently pursuing FDA Class IIb device MDR (2017/745) certification targeted for Q2. The AI technology is not cleared by the FDA for clinical diagnostic use in the USA.
Skinmed dermatology platform is considered non-medical MDDS.
Our platform already meets strict European data protection standards and follows clinical best practices for telehealth delivery.
Where can we meet the Skinmed team?
Where can we meet the Skinmed team?
Join us at these upcoming events in January 2026:
🎯 CES 2026 - Las Vegas
January 6-9, 2026
Digital Health Summit
Meet us at the world's premier technology event to explore how Skinmed is democratizing dermatology through AI-enhanced telehealth.
💼 J.P. Morgan Healthcare Conference - San Francisco
January 12-15, 2026
44th Annual Healthcare Investment Symposium
Schedule a meeting to discuss investment opportunities, partnership strategies, and our global expansion roadmap.
Your questions.
Answered.
Not sure where to start? These answers might help you feel more confident as you begin.
How does Skinmed work?
Skinmed makes expert dermatology accessible through your local pharmacy. Simply visit a Skinmed-enabled location where a trained pharmacist will capture high-definition images of your skin concern using medical-grade equipment. Your images are securely transmitted to board-certified dermatologists who review every case and provide a detailed report within 48 hours.
If specialist care is needed, we coordinate referrals and follow-up. No appointments, no long waits — just accessible expert care when you need it.
How does Skinmed work?
Skinmed makes expert dermatology accessible through your local pharmacy. Simply visit a Skinmed-enabled location where a trained pharmacist will capture high-definition images of your skin concern using medical-grade equipment. Your images are securely transmitted to board-certified dermatologists who review every case and provide a detailed report within 48 hours.
If specialist care is needed, we coordinate referrals and follow-up. No appointments, no long waits — just accessible expert care when you need it.
Is Skinmed available in my area?
Is Skinmed available in my area?
Skinmed currently operates through 1000+ partner pharmacies across France, with rapid expansion underway.
US pilot programs are launching in 2026. To find a Skinmed-enabled pharmacy near you or to express interest in bringing Skinmed to your community, contact us directly.
How accurate is the diagnosis?
How accurate is the diagnosis?
Every Skinmed diagnosis undergoes mandatory review by board-certified dermatologists registered with medical authorities. Our AI-powered pre-screening assists triage, but 100% of final diagnoses are validated by human experts.
Our 2024 clinical study demonstrates concordance between Skinmed diagnoses, in-person dermatology consultations, and pathology results.
Quality and accuracy are never compromised for speed.
What conditions can Skinmed screen for?
What conditions can Skinmed screen for?
Skinmed screens for a wide range of skin conditions including:
Melanoma and other skin cancers (basal cell, squamous cell)
Pre-cancerous lesions (actinic keratosis)
Atypical moles requiring monitoring
Common dermatological conditions (eczema, psoriasis, rosacea)
Suspicious lesions requiring specialist evaluation
Our platform provides risk-stratified recommendations: routine monitoring, primary care follow-up, dermatologist consultation, or urgent specialist referral.
What is Skinmed's regulatory status?
What is Skinmed's regulatory status?
Skinmed operates as a GDPR-compliant telehealth platform in France.
All dermatologists are licensed and registered with French medical authorities (RPPS).
The AI technology (developed by ANAPIX Medical) is currently pursuing FDA Class IIb device MDR (2017/745) certification targeted for Q2. The AI technology is not cleared by the FDA for clinical diagnostic use in the USA.
Skinmed dermatology platform is considered non-medical MDDS.
Our platform already meets strict European data protection standards and follows clinical best practices for telehealth delivery.
Where can we meet the Skinmed team?
Where can we meet the Skinmed team?
Join us at these upcoming events in January 2026:
🎯 CES 2026 - Las Vegas
January 6-9, 2026
Digital Health Summit
Meet us at the world's premier technology event to explore how Skinmed is democratizing dermatology through AI-enhanced telehealth.
💼 J.P. Morgan Healthcare Conference - San Francisco
January 12-15, 2026
44th Annual Healthcare Investment Symposium
Schedule a meeting to discuss investment opportunities, partnership strategies, and our global expansion roadmap.
Didn’t find your answer? Send us a message — we’ll respond with care and clarity.
Your questions.
Answered.
Not sure where to start? These answers might help you feel more confident as you begin.
Didn’t find your answer? Send us a message — we’ll respond with care and clarity.
How does Skinmed work?
Skinmed makes expert dermatology accessible through your local pharmacy. Simply visit a Skinmed-enabled location where a trained pharmacist will capture high-definition images of your skin concern using medical-grade equipment. Your images are securely transmitted to board-certified dermatologists who review every case and provide a detailed report within 48 hours.
If specialist care is needed, we coordinate referrals and follow-up. No appointments, no long waits — just accessible expert care when you need it.
How does Skinmed work?
Skinmed makes expert dermatology accessible through your local pharmacy. Simply visit a Skinmed-enabled location where a trained pharmacist will capture high-definition images of your skin concern using medical-grade equipment. Your images are securely transmitted to board-certified dermatologists who review every case and provide a detailed report within 48 hours.
If specialist care is needed, we coordinate referrals and follow-up. No appointments, no long waits — just accessible expert care when you need it.
Is Skinmed available in my area?
Is Skinmed available in my area?
Skinmed currently operates through 1000+ partner pharmacies across France, with rapid expansion underway.
US pilot programs are launching in 2026. To find a Skinmed-enabled pharmacy near you or to express interest in bringing Skinmed to your community, contact us directly.
How accurate is the diagnosis?
How accurate is the diagnosis?
Every Skinmed diagnosis undergoes mandatory review by board-certified dermatologists registered with medical authorities. Our AI-powered pre-screening assists triage, but 100% of final diagnoses are validated by human experts.
Our 2024 clinical study demonstrates concordance between Skinmed diagnoses, in-person dermatology consultations, and pathology results.
Quality and accuracy are never compromised for speed.
What conditions can Skinmed screen for?
What conditions can Skinmed screen for?
Skinmed screens for a wide range of skin conditions including:
Melanoma and other skin cancers (basal cell, squamous cell)
Pre-cancerous lesions (actinic keratosis)
Atypical moles requiring monitoring
Common dermatological conditions (eczema, psoriasis, rosacea)
Suspicious lesions requiring specialist evaluation
Our platform provides risk-stratified recommendations: routine monitoring, primary care follow-up, dermatologist consultation, or urgent specialist referral.
What is Skinmed's regulatory status?
What is Skinmed's regulatory status?
Skinmed operates as a GDPR-compliant telehealth platform in France.
All dermatologists are licensed and registered with French medical authorities (RPPS).
The AI technology (developed by ANAPIX Medical) is currently pursuing FDA Class IIb device MDR (2017/745) certification targeted for Q2. The AI technology is not cleared by the FDA for clinical diagnostic use in the USA.
Skinmed dermatology platform is considered non-medical MDDS.
Our platform already meets strict European data protection standards and follows clinical best practices for telehealth delivery.
Where can we meet the Skinmed team?
Where can we meet the Skinmed team?
Join us at these upcoming events in January 2026:
🎯 CES 2026 - Las Vegas
January 6-9, 2026
Digital Health Summit
Meet us at the world's premier technology event to explore how Skinmed is democratizing dermatology through AI-enhanced telehealth.
💼 J.P. Morgan Healthcare Conference - San Francisco
January 12-15, 2026
44th Annual Healthcare Investment Symposium
Schedule a meeting to discuss investment opportunities, partnership strategies, and our global expansion roadmap.